Volume 25, Number 2—February 2019
Research
Oasis Malaria, Northern Mauritania1
Table 5
Age group, y | No. PCR-positive patients |
Total no. (%) | ||
---|---|---|---|---|
No travel history | Travel to nonendemic regions | Travel to endemic regions† | ||
<5 | 2 | 0 | 5 | 7 (4.6) |
5–9 | 3 | 0 | 0 | 3 (2.0) |
10–15 | 8 | 0 | 12 | 20 (13.2) |
>15 | 35 | 10 | 76 | 121 (80.1) |
Total, no. (%) | 48 (31.8) | 10 (6.6) | 93 (61.6) | 151 (100) |
*Travel history within 6 months before consultation was obtained for 435 febrile patients. Of 162 PCR-positive malaria patients, travel history was available for 151 patients.
†Endemic regions include Nouakchott, the entire southern Sahelian zone of Mauritania, and sub-Saharan Africa countries.
1Preliminary results of this study were presented at the 7th Multilateral Initiative for Malaria (MIM) Pan African Malaria Conference, April 15–20, 2018, Dakar, Senegal.
Page created: January 18, 2019
Page updated: January 18, 2019
Page reviewed: January 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.